THE FORTIS AUDIT AND ITS IMPLICATIONS FOR CORPORATE INDIA
The Delhi High Court’s order of 31 August 2026 brings a fully cleared change-in-control transaction within the scope of a forensic audit. The IHH–Northern TK Venture acquisition of control in Fortis Healthcare (Fortis) was approved by the board and shareholders, cleared by the CCI, and completed under the SEBI Takeover Regulations through an open offer SEBI itself permitted. Neither IHH nor Fortis was a party to the arbitration, the award or the execution proceedings, and the Court has imposed no liability, penalty or fine on either.
The exposure reaches individual officers of a listed company, on an open-ended clock. The audit covers Fortis’ officers, KMPs, Company Secretary, Compliance Officer, RTA and depositories, with failure to meet a requisition treated as contempt. Officers appointed years after the conduct examined are personally exposed, in proceedings listed next on 1 April 2027.
Public shareholders bear the cost whether or not liability ever attaches. About 69% of Fortis is publicly held. Those shareholders carry the disclosure overhang, the diverted management bandwidth, and the residual possibility recorded in the order that reverse veil piercing may fall for consideration against the operating company at a later stage. The Court has made clear that the audit is a fact-finding exercise and does not itself impose liability. But fact-finding is not cost-free: it consumes management and legal resources, creates reputational overhang and can affect investor confidence. Capital is mobile and investors have alternatives; prolonged uncertainty can therefore have consequences for the company and its shareholders.
The enforcement objective is legitimate; the governance question is what a bona fide acquirer may rely on. A decree holder is entitled to have the dissipation of its judgment debtors’ assets traced. The narrower question for the market is whether a transaction that has cleared the entire approval architecture — board, shareholders, CCI, SEBI, the Takeover Code — ever becomes settled. Indian law supplies no answer.
The remedy is institutional, not judicial. An executing court cannot supply a rule of finality that the statutes do not contain. SEBI (and, if required, the MCA/Parliament) should confer defined finality on a change in control completed under the Takeover Regulations after regulatory clearance, prescribe when a non-party listed company may be drawn into execution proceedings against its former promoters, and protect officers discharging statutory functions from personal coercive exposure for conduct predating their appointment.
Comments